Navigation Links
Bausch & Lomb Launches Multi-Tiered U.S. Consumer Education Initiative to Raise Awareness of Presbyopia
Date:3/12/2009

sion Multi-Focal contact lenses are perfect for the busy wearer who wants contact lenses that stay comfortable all day and can be replaced as little as once a month. Built with the comfort-enhancing AerGel(TM) material, they also repel debris and allow natural levels of oxygen for healthy, white eyes. Bausch & Lomb SofLens(R) Multi-Focal contact lenses are also available, and both products provide exceptional vision and all-day comfort, along with Bausch and Lomb's #1 Multi-Focal lens design.

About Bausch & Lomb

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the Company employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information about the company can be found at www.bausch.com.

(R)/TM denote trademarks of Bausch & Lomb Incorporated.


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development
2. Bausch & Lomb Survey Shows People with Astigmatism Unaware of Contact Lens Options
3. Bausch & Lombs Crystalens to be Featured in Florida Advertising Campaign.
4. Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
5. Home Care Delivered, Inc. Launches Proprietary Insurance Payer Management System
6. 23andMe Launches Parkinsons Disease Genetics Initiative
7. CSC Launches New Enterprise Data Loss Prevention Service
8. Perot Systems Launches Webinar Series and Website Resources on Healthcare Stimulus Plan Provisions
9. RWJF launches $19 million public health law research program
10. Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017
11. SynergEyes(R) Launches a New Website for Keratoconus Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...w number of new cases created by a single case of ...s such as vaccination, social distancing and the u... impact of the virus, suggests an epidemiological ...3/cmaj.091807 reported in CMAJ ( Canadian Medi...study looked at data from laboratory-confirmed cas...
(Date:12/3/2009)... Each year, editors of the Harvard Health Le...orial board, choose the top 10 health stories of t...r 2009. , Boston (Vocus) ...vard Health Letter , in consultation with the doct...th stories of the year. Here are four of the items...
(Date:12/3/2009)... Henninger,s creative staff caps off success...ction work and 5 awards for post production servic... 2009 -- The 13th Annual TIVA Peer Awards were pre... National Press Club in Washington, D.C. last week...o;) capped off a successful year for its creative ...
(Date:12/3/2009)...la., Dec. 3 This holiday season, f...rippling back and neck pain are putting a differen... spinal disorders through minimally-invasive endos...techniques at Laser Spine Institute (LSI). With ...delphia, LSI is revolutionizing spinal procedures ...
(Date:12/3/2009)...ged from hospitals on ventilator support and with ...er. Researchers from the Frances Payne Bolton Sch...report these findings in American Journal of Crit...mportant outcome for patients," says Barbara Daly,... Health-funded study, "Composite Outcomes of Chron...
Breaking Medicine News(10 mins):Health News:Vaccination, antivirals and social distancing may blunt impact of H1N1 influenza 2Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 2Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 3Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 4Health News:Henninger Media Services Wins 9 TIVA Peer Awards 2Health News:Henninger Media Services Wins 9 TIVA Peer Awards 3Health News:Give the Gift of Relief for the New Year 2Health News:CWRU researchers report poor outcomes for CCI patients leaving hospitals on ventilators 2
...helps Aesculap Implant Systems stay abreast of ong...s, DURANGO, Colo., April 8, 2008 Syndicom, the p...ay announced that the company is,providing its onl... focusing on Spine and Orthopaedic devices. With t...
...in Fraudulent Asks Top Acupuncture Physician, SOU...hought it was safe to get acupuncture yet one more...ht to be shamelessly under qualified. This,time it...ne, difficult,and chronic pain, shingles, autism a...
...mences for Issuance of Certification to Operate HM...nagement Group, Inc. (Phyhealth) (Pink Sheets: PHY...s (HMOs) in partnership with physicians,today anno...encies requiring them. Applications were accepted ...
...st advance in waking up since coffee, SPARTA, N.J...e morning feeling refreshed and ready to go, you,r... from work and school performance to spousal,relat...ill help you to wake up in the morning., Wake Up ...
...la., April 8, 2008 Throw down your,mop and broom!...n out,something really important -- your body. Dai...ent, food, cosmetics, and household cleaning produ...0408/NYFNSF06 ), "Ideally, you should cleanse wi...
...ril 8, 2008 Morris "Mo" Moses and his,wife Ida th...,s health. A,Type II diabetic, with multiple medic...on the bottom of his right foot which just wouldn,...ticut, diagnosed it as a diabetic ulcer and Greenb...
Other Medicine News:Health News:Syndicom's Collaborative Web Platform Chosen to Facilitate Clinical Trials for Lumbar Disc Device from Aesculap Implant Systems 2Health News:SNAP! CRACKLE! POP! Untrained Chiropractors Doing Acupuncture! 2Health News:Phyhealth HMO Applications Accepted by All Required Federal and State Agencies 2Health News:Tired Mother Invents Pill to Wake You Up On Time 2Health News:Spring Clean Your Body for the Perfect Cleanse 2Health News:Living Cell Treatment Heals Diabetic Foot Sores Fast 2
(Date:12/3/2009)... , , ST. PAUL, Minn., Dec. 3 /PRNewswire/ ...ompany, announced that it has completed a second r...ion. The funds will be used to complete a clinical...rietary implantable technology designed to treat o...n the financing include Domain Associates, New Ent...
(Date:12/3/2009)... , , ADDISON, Texas, Dec. 3 /PRNewswire-... today that McKesson Medical-Surgical, Inc., one o...ted States, has approved ULURU Inc. to be one of i...order for Altrazeal(TM). McKesson Medical-Surgical...ical supplies, medical equipment and health care t...
(Date:12/3/2009)... , , MARQUETTE, Mich., Dec. 3 /PRNewswire...driven leader in innovative medical devices, recei...t the 2009 Spine Technology Awards gala held recen...th the North American Spine Society annual meeting...ogies receiving awards were the NuNec® Cervic...
Breaking Medicine Technology:Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3ULURU Inc. Obtains Status of Approved Supplier With McKesson. 2Pioneer(R) Surgical Technology, Inc. Receives Prestigious Spine Technology Awards 2Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 1Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 2Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 3Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 4Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 5Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 6Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 7Abbott Hosts Conference Call for Third Quarter Earnings 14252 1Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 1Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 3Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 4
FirstChoice Drainable Pouches, Convex
FirstChoice Drainable Pouch, FlexWear, Cut-to-Fit
FirstChoice Drainable Kit
FirstChoice Closed Pouches
Medicine Products: